Breast Cancer Index Identifies Who Will Benefit From Prolonged Therapy, New Data Shows
Biotheranostics’ Breast Cancer Index can help distinguish which breast cancer patients will derive a benefit from prolonged endocrine therapy — allowing those who don’t to stop treatment and avoid its unpleasant side effects, new data suggests....Acupuncture Helps Breast Cancer Survivors Beat Joint Pain
Women who have survived breast cancer are often prescribed aromatase inhibitors to help prevent recurrences, but the drugs can cause the unpleasant side effect of joint pain. A new study finds that acupuncture offers the most relief from the pain. Source: Acupuncture...How hormone-disrupting chemicals may harm our health: Video
Evidence suggests chemicals like pesticides and phthalates may be linked to serious diseases like obesity, diabetes, brain disorders and fertility problems. It’s detailed in Dr. Leonardo Trasande’s new book, “Sicker, Fatter, Poorer: The Urgent Threat...Younger Breast Cancer Patients at Higher Risk for Osteoporosis
Investigators found that incident osteopenia and osteoporosis are significantly higher in young survivors of breast cancer. Source: Younger Breast Cancer Patients at Higher Risk for Osteoporosis – Cancer Therapy...Younger Breast Cancer Patients at Higher Risk for Osteoporosis
Younger survivors of breast cancer appear to be at higher risk for osteopenia and osteoporosis compared with cancer-free women
Can Topical Drugs Help Prevent Breast Cancer?
A topical form of tamoxifen, called 4-OHT, is being tested to see if it can prevent breast cancer as effectively as oral tamoxifen but with fewer side effects. Source: Can Topical Drugs Help Prevent Breast Cancer? – National Cancer...Hormone Therapy for Breast Cancer May Cause Diabetes
Hormone therapy was linked with a much higher risk of developing diabetes (hazard ratio [HR], 2.4). The risk was particularly high among those who received an aromatase inhibitor (HR, 4.27), though was still noted among those who received tamoxifen (HR, 2.25). Source:...How to avoid hormone disrupting chemicals
“The evidence for adverse reproductive outcomes (infertility, cancers, malformations) from exposure to endocrine disrupting chemicals is strong, and there is mounting evidence for effects on other endocrine systems, including thyroid, neuroendocrine, obesity and...Test Measures Women’s Cancer Recurrence Risk After Hormone Therapy
If doctors knew a woman’s risk of late distant recurrence, they could recommend extended hormonal therapy only for women who would benefit from it. CTS5 was able to accurately separate the women into groups of low, intermediate, or high risk of late distant recurrence after 5 years of hormonal therapy. The tool found 42% of the women had low late distant recurrence risk, so the risks of extended hormonal therapy outweighed the benefits for these women.
The problem with all the plastic that’s leaching into your food
Most of our food containers — from bottles to the linings in aluminum cans to plastic wraps and salad bins — are made using polycarbonate plastics, some of which have bioactive chemicals, like bisphenol A (BPA) and phthalates. These man-made chemicals can leach from the containers or wrappings into the food and drinks they’re holding — especially when they’re heated. Research released earlier this year found that more than 90 percent of bottled water from the world’s leading brands was contaminated with microplastics, sparking a review of plastics in drinking water by the World Health Organization.
Vitamin D may decrease breast cancer risk, study reports
Vitamin D is crucial to our health, and now, new research has found a ‘marked’ association between blood levels of this vitamin and breast cancer risk. Source: Vitamin D may decrease breast cancer risk, study...Common drug may help battle aggressive breast cancer
Zoledronic acid directly inhibits UGT8 and is already in widespread use. In fact, this medication is on the World Health Organization’s (WHO) list of safe and effective medicines that are deemed “essential for global health.
Low Muscle Mass and Breast Cancer Survival
In one of the largest investigations of its kind conducted to date, researchers found that one-third of the women included in the study had low levels of skeletal muscle mass—a condition known as sarcopenia—at the time of their diagnosis. And having low levels of muscle mass was associated with a higher risk of dying compared with women who had adequate muscle mass, the researchers reported April 5 in JAMA Oncology.
Disrupting normal hormone cycle spurs fat cells
In mice, interfering with the natural cycle of a certain hormone spurs development of more fat cells.This finding may help explain why stress and conditions associated with abnormal steroid hormone levels can cause obesity. Source: Disrupting normal hormone cycle...What is the Smart Body Mass Index?
The SBMI calculator functions on the basis of the newly developed Smart Body Mass Index. The SBMI differs from the BMI in three important aspects. Firstly, it takes age and sex into account, besides weight and height. Secondly, the SBMI is a purely comparative figure...Breast Cancer: How Long on Aromatase Inhibitors Is Long Enough?
Women with breast cancer who are prescribed aromatase inhibitors (AI) such as Arimidex (anastrozole) and Femara (letrozole) don’t need to take the medication for more than two additional years following the standard five-year treatment period, according to research presented at the 2017 San Antonio Breast Cancer Symposium in December.
Listen to Dr. Janet Maker's
Interview with Melanie Young
of Fearless Fabulous You
June 27, 2018 on W4WN Network
Listen to Dr. Janet Maker's Interview with Dr. Drew
June 4, 2018 on 790 KABC